Abstract:The mechanism of neuronal loss in Alzheimer's disease (AD) remains unknown, although circumstantial evidence of apoptosis in postmortem brain tissues has supported the hypothesis that an apoptotic mechanism plays a role in the neurodegeneration in AD. Mutations in presenilins 1 and 2 (PS1/2) are responsible for the majority of familial AD. These proteins are localized predominantly in the endoplasmic reticulum (ER) and Golgi apparatus, and form heteromeric protein complexes to participate in several functions. Previous studies have shown that PS1/2 are involved in the regulation of apoptotic cell death, although the molecular basis is still unresolved. The aim of this study is to clarify the molecular basis by which PS1/2 regulate apoptosis. We also address a question how presenilin mutations modify the regulatory activity. We performed yeast 2–hybrid screen, co–immunoprecipitation assay, glycerol velocity gradient centrifugation and subcellular fractionation with iodixanol gradient, using HEK293 cells, PS1/2–knockout mouse fibroblasts and I213T–PS1–knockin mouse brains. PS1/2 interacted with FKBP38 that is an immunophilin family member residing in the mitochondrial membrane and inhibits apoptosis by targeting and anchoring anti–apoptotic Bcl–2 to the mitochondria. PS1/2 and FKBP38 formed macromolecular complexes together with Bcl–2. This complex formation promoted the degradation of FKBP38 and Bcl–2, and sequestered these proteins in the ER/Golgi compartments, thereby inhibiting FKBP38–mediated mitochondrial targeting of Bcl–2. Thus, full–length PS1/2 increased the susceptibility to apoptosis by antagonizing the anti–apoptotic function of FKBP38. In contrast, C–terminal fragments of caspase–processed PS1/2 redistributed Bcl–2 to the mitochondria by abrogating the activity of full–length PS1/2, resulting in a dominant–negative anti–apoptotic effect. In cultured cells and mutant PS1–knockin mouse brains, familial AD–linked PS1/2 mutants enhanced the pro–apoptotic activity by causing a more efficient reduction in mitochondrial Bcl–2 than wild–type PS1/2. We demonstrated that PS1/2 regulate the susceptibility to apoptosis by interacting with FKBP38. These results suggest a novel molecular mechanism for the regulation of mitochondria–mediated apoptosis by competition between PS1/2 and FKBP38 for subcellular targeting of Bcl–2. Furthermore, familial AD–linked mutations in PS1/2 could lower the threshold for activation of mitochondria–mediated apoptosis pathways in neurons of individuals with familial AD.

Role of Presenilins in Neuronal Calcium Homeostasis

Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.

Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer’s Disease

Presenilin-Mediated Modulation of Capacitative Calcium Entry

A Role for Presenilin in Post-Stress Regulation: Effects of Presenilin Mutations on Ca2+ Currents in Drosophila

Calcium Signaling, Excitability, and Synaptic Plasticity Defects in a Mouse Model of Alzheimer's Disease.

Presenilins are essential for regulating neurotransmitter release

Pathological and Physiological Functions of Presenilins

The presenilins and Alzheimer's disease

Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations

Aberrant miR-339-5p/neuronatin signaling causes prodromal neuronal calcium dyshomeostasis in mutant presenilin mice

Inactivation of Presenilins Causes Pre-Synaptic Impairment Prior to Post-Synaptic Dysfunction.

P3-402: Pathogenic Mutations of Presenilins Enhance Pro-Apoptotic Activity by Reducing Mitochondrial Bcl-2

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

Insights into membrane-bound presenilin 2 from all-atom molecular dynamics simulations

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

Ca2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles

Interaction of Presenilins with FKBP38 Promotes Apoptosis by Reducing Mitochondrial Bcl-2.

A Multi-Functional Molecule in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases

Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca2+ signaling in two rodent models of Alzheimer’s disease